Abstract: Methods for identifying antigens as potential biomarkers for the early detection of ovarian cancer, as well as kits for utilizing said antigens as biomarkers and in personalized medicine/therapeutics assessment. Protein microarrays displaying full-length candidate antigens were developed and sequentially screening to select candidate autoantibody biomarkers to limit the false discovery rate inherent to large-scale proteomic screening.
Type:
Application
Filed:
January 30, 2014
Publication date:
December 17, 2015
Applicant:
Arizona Board of Regents on behalf of Arizona Stat State University
Inventors:
Karen Anderson, Joshua LaBaer, Garrick Wallstrom, Daniel Cramer